Mostrando 10 resultados de: 18
Publisher
Current Pharmaceutical Design(2)
European Endocrinology(2)
International Journal of Environmental Research and Public Health(2)
International Journal of Molecular Sciences(2)
Anales del Sistema Sanitario de Navarra(1)
Área temáticas
Enfermedades(16)
Fisiología humana(10)
Farmacología y terapéutica(2)
Ginecología, obstetricia, pediatría, geriatría(2)
Salud y seguridad personal(2)
Área de conocimiento
Medicina interna(6)
Diabetes(5)
Obesidad(5)
Bioquímica(2)
Enfermedad cardiovascular(2)
Hypertension, emotions and happiness: A brief view from the biology to the positive psychology
ArticleAbstract: High blood pressure (HBP) is a silent disease with an extremely high prevalence worldwide. It is conPalabras claves:Cardiovascular disease, happiness, HEALTH, Hypertension, psychosocialAutores:Bautista-Sandoval M.J., Castro A., Chaparro-Suárez Y.K., Díaz-Camargo E.A., Durán P., D’marco L., González M.C., Nava M., Ortiz O.M., Parra H., Riaño-Garzón M.E., Rojas E.R., Valmore BermúdezFuentes:scopusEpicardial adipose tissue, adiponectin and leptin: A potential source of cardiovascular risk in chronic kidney disease
ReviewAbstract: The importance of cardiometabolic factors in the inception and progression of atherosclerotic cardioPalabras claves:adiponectin, Cardiovascular disease, Epicardial adipose tissue, leptinAutores:D’marco L., Lima-Martínez M., Puchades M.J., Raggi P., Romero-Parra M., Soto C., Teruel J.L., Valmore BermúdezFuentes:scopusEpicardial adipose tissue: A cardiovascular risk marker to evaluate in chronic kidney disease
ReviewAbstract: Chronic kidney disease represents a true inflammatory state, and is related to multiple cardiovasculPalabras claves:Cardiovascular Risk, Chronic kidney disease, Epicardial adipose tissue, vascular calcificationAutores:Cortez M., D’marco L., Lima-Martínez M., Salazar M., Valmore BermúdezFuentes:scopusFinerenone: A potential treatment for patients with chronic kidney disease and type 2 diabetes Mellitus
ReviewAbstract: Type 2 diabetes mellitus (T2DM) affects an estimated 463 million people worldwide, equivalent to 1 iPalabras claves:cardiovascular diseases, Chronic kidney disease, Diabetic nephropathies, FinerenoneAutores:D’marco L., Forquet C., Gandía L., Giménez-Civera E., Juan-García I., Panizo N., Puchades M.J., Reque J., Teruel J.L., Valmore BermúdezFuentes:scopusEtelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation
ArticleAbstract: Introduction: secondary hyperparathyroidism (SHP) is frequent in patients with chronic kidney diseasPalabras claves:calcimimetics, Chronic kidney disease, inflammation, vitamin D analogsAutores:Checa-Ros A., Dapena F., D’marco L., Gamero D., Nava M., Salazar J., Soto C., Valmore BermúdezFuentes:scopusClinical and nutritional implications of kidney disease and COVID-19
ReviewAbstract: By the end of 2019 emerged a cluster of pneumonia that was caused by a novel SARS-CoV-2 virus. The dPalabras claves:acute kidney injury, Chronic kidney disease, Clinical nutrition, covid-19, nutritional, SARS-COV-2Autores:Albornoz C., Ariza D., Carrasquero R., D’marco L., Guerra-Torres X.E., Morillo V., Nava M., Valmore Bermúdez, Vasquez H.E.A.Fuentes:scopusAnti-aging effect of metformin: A molecular and therapeutical perspective
ReviewAbstract: Aging is a time-dependent inevitable process, in which cellular homeostasis is affected, which has aPalabras claves:ageing, Anti-ageing drugs, Geronto-protective properties, Metformin, Type 2 Diabetes mellitusAutores:Cano-Ponce C., D’marco L., Galbán N., Gomez Y., González M.C., Herazo Y., Morillo V., Nava M., Rojas M., Rojas-Quintero J., Torres W., Valmore Bermúdez, Velasco M.Fuentes:scopusAdvanced glycation end products: New clinical and molecular perspectives
ArticleAbstract: Diabetes mellitus (DM) is considered one of the most massive epidemics of the twenty-first century dPalabras claves:Advanced glycation end products, Chronic complications, diabetes mellitus, Skin fluorescenceAutores:Cabrera M., Dávila L.C.A., D’marco L., González M.C., Hernández M., Morillo D., Nava M., Navarro C., Ortega A., Rina Ortiz, Salazar-Vílchez J., Torres W., Valmore BermúdezFuentes:scopusAge-specific waist circumference cutoff-points for abdominal obesity diagnosis: a personalized strategy for a large Venezuelan population
ArticleAbstract: Background: Evidence shows that the ageing process is a determining factor in fat distribution, compPalabras claves:aging, Coronary artery disease, Hypertension, Metabolic syndrome, obesity, Waist circumferenceAutores:Añez-Ramos R., Cano-Ponce C., D’marco L., González M.C., Martínez M.S., Nava M., Olivar L.C., Ortega A., Rodriguez J.E., Rojas M.P., Rojas-Quintero J., Salazar-Vílchez J., Toledo A.C., Valmore BermúdezFuentes:scopusInsulin withdrawal in diabetic kidney disease: What are we waiting for?
ArticleAbstract: The prevalence of type 2 diabetes mellitus worldwide stands at nearly 9.3% and it is estimated thatPalabras claves:Cardiovascular disease, Diabetic kidney disease, GLP-1RA, Insulin, SGLT2iAutores:D’marco L., Gorriz-Zambrano C., Morillas C., Puchades M.J., Solá-Izquierdo E., Teruel J.L., Valmore BermúdezFuentes:scopus